Omalizumab for food allergy skin effects
Treatments studied
Part of Immune system & allergy clinical trials.
This trial tests if omalizumab (Xolair) can improve skin reactions in people with food allergies. It may help reduce allergic symptoms triggered by foods like peanut, egg, or milk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 55 years old.
- You have a confirmed food allergy to peanut, egg, tree nut, sesame, milk, wheat, or soy.
- Your IgE level and weight must allow a safe omalizumab dose.
- You must be willing to use birth control if you could become pregnant.
- You cannot have severe asthma or eczema that is not well controlled.
- You must stop certain allergy medicines (like antihistamines) before the food challenge.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if omalizumab (a drug that blocks allergy reactions) can help people with multiple food allergies. You might qualify if you have severe allergies to at least two foods like peanut, tree nuts, egg, or milk.
This trial studies an oral immunotherapy approach, where children take tiny, controlled amounts of certain allergy-causing foods to build tolerance. It may help reduce allergic reactions, but only if kids meet safety and monitoring requirements.
This trial tests a slow, multi-food oral immunotherapy (giving small amounts of several foods) in young children with food allergies. It aims to see if this treatment can help children safely eat more foods without allergic reactions.
This study tests if omalizumab (Xolair), an injectable medicine that blocks allergy antibodies, can help people with food allergies tolerate small amounts of their trigger foods. It's for people with high total IgE levels who were not eligible for a related study.
This trial tests a drug called omalizumab for people with plant-food allergies caused by two specific proteins: LTP (found in peach skin) and profilin (found in melon). The goal is to see if the drug can help reduce allergic reactions.
This trial tests if omalizumab, an allergy medication, can help people with COPD who have allergies to common indoor triggers like cat, dog, mouse, cockroach, or dust mite. It aims to reduce flare-ups and improve breathing.
Hear when a new Food Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.